3 July 2020 Australian Clinical Trials Alliance commends the Health Minister’s vision to expedite clinical trials in Australia Australian Clinical Trials Alliance (ACTA) has welcomed the announcement by the Health…
…and membership To know more about ACTA and ACTA STInG, please follow us on Twitter here, Linkedin here To become an ACTA Member, please visit https://clinicaltrialsalliance.org.au/membership/ Or subscribe to the ACTA newsletter at https://clinicaltrialsalliance.org.au/about-acta/…
Stakeholder mapping enables the identification and engagement of key opinion leaders, organisations, and groups vital for the establishment and growth of a clinical trial network (CTN)….
The Australian Clinical Trials Alliance (ACTA) has been granted $5 million over four years through the Medical Research Future Fund (MRFF) to continue delivering its vision of ‘Better health through…
…received after Monday, 23 November 2020 will receive no refund. Disclaimer: The program is correct at the time of publishing. The Organising Committee reserves the right to delete, modify or…
A facilitated workshop for Primary Health Care Clinical Researchers 14 August 2020 The Australian Clinical Trials Alliance, (ACTA), CTN Expansion Reference Group in collaboration with the Australasian Association for Academic…
…emerging Clinical Trial Network groups (CTNs). Develop an understanding of the structure, organisation and financing of a CTN. Develop an understanding of the benefits and risks of establishing a CTN…
The advent of COVID-19 has necessitated the rapid adoption of new models of care delivery to facilitate remote health care access. This online Telehealth clinical challenges workshop will be facilitated by Professor…
The Australian Clinical Trials Alliance (ACTA) has recognised the remarkable Australians who advance the health system through clinical trials at the virtual Clinical Trials 2020: National Tribute and Award Ceremony….
Australian Academy of Health and Medical Sciences urges multi-pronged response for 2021 High levels of testing, efficient vaccine distribution and addressing pandemic mental health impacts are critical if Australia is…
Comparative effectiveness (CE) research and trials (CETs) are recognised across Australia for their importance in generating real-world data that can be readily implemented to improve healthcare outcomes. This type of…
The purpose of the webinar was to build awareness and capacity for HREC members, research governance personnel and their organisations, to effectively review, support and further implement consumer involvement activities…
CTN risks can be categorised into organisational, CTN, study, site and operational-level risks. These risks may vary according to site experience and location. Clinical trial risks can also be categorised…
Are you interested in finding better pain management solutions for people with cancer? Join us on Tuesday 23 February at 2pm for an online workshop to discuss and explore study…
The AGITG Annual Scientific Meeting serves not only as a forum for the presentation of state-of-the art overviews on the pathobiological and clinical aspects of GI cancer, but also affords…
Consumers and researchers tell their personal stories of the value and impact of consumer involvement in clinical trials in three new ACTA-produced videos that have just become available online. The…
HeSANDA Stakeholder Consultation Project: Pre-reading for stakeholder consultation participants This information is for people participating in the HeSANDA Stakeholder Consultation Project. Your participation in the consultation will rely on you…
The Australian Clinical Trials Alliance (ACTA) is delighted to announce Prof Steve Webb MBBS MPH PhD FCICM FRACP FAHMS as its new Chair, effective 20 May 2021….
Join ACTA and a panel of experts, including researchers and consumers, on 28 July 2021 (11-12pm AEST) as we share our work on applying a simplified (integrated) consent approach in…
The Australian Clinical Trials Alliance (ACTA) welcomes the opportunity to respond to the Parliamentary Inquiry into approval processes for new drugs and novel medical technologies in Australia. The inquiry is…
This webinar provides the background and context for the stakeholder consultation. Specifically, how it fits into the scope of the ARDC HeSANDA initiative project. Please be sure to watch the…
Lung Foundation Australia, in partnership with the Thoracic Society of Australia & New Zealand, and the Centre of Research Excellence in Pulmonary Fibrosis is hosting the 5th Biennial Australasian Rare…
Equity and Innovation in Multidisciplinary Lung Cancer Care The TOGA 2021 ASM will provide an opportunity for our multidisciplinary membership to come together to learn of advances in quality thoracic…
You are invited to join a webinar hosted by Dr Masha Somi, Chief Executive Officer of the Health and Medical Research Office (HMRO) to learn more about the Medical Research…
The purpose of this tool is to self-assess the presence and effectiveness of the success factors that were identified in the “Activities critical to success and growth of Clinical Trials…
The report, Australia’s Clinical Trials Sector: Advancing innovative healthcare and powering economic growth, developed through extensive and whole-of-sector stakeholder engagement, provides a snapshot of the size and scope of Australia’s…
The CHecklist for statistical Assessment of Medical Papers (CHAMP) helps with the process of peer reviewing the statistical aspects of a manuscript to ensure that the statistics used in paper…
A discussion paper that describes how consent could be better integrated into clinical care….
An example participant information sheet template which can be adapted for use in other studies….
A feasibility report that confirms the National Statement both permits and encourages a flexible approach to consent, so that participant information sheets address variations in the needs or characteristics of…
Published in Trials journal, this article provides trialists with a tool to consider a range of areas in which practical action could enhance the implementability of trials. This open access…
The Australian Trials Methodology (AusTriM) Research Network is an NHMRC Centre of Research Excellence devoted to the development, evaluation and application of innovative clinical trial methodology. The network is offering…
Over 180 participants joined us in a webinar on 28 July 2021 where we launched a series of resources related to simplified consent in comparative effectiveness trials (CETs). These resources are…
This summary outlines the key themes emerging from a targeted consultation process facilitated by ACTA on behalf of the Australian Research Data Commons (ARDC) to inform the planning and design…